Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project

NCT01543113 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT01543113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01543113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project
Lead sponsor
Rennes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
February 28, 2014
Enrollment
288 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma